How Do Regulatory Authorities Address Emerging Technologies?
Emerging technologies, such as personalized medicine and immunotherapy, are transforming cancer treatment. Regulatory authorities are adapting their frameworks to accommodate these advancements. They are developing new guidelines and pathways to evaluate these innovative treatments while ensuring safety and efficacy. Collaborative efforts with academic institutions and industry stakeholders are crucial in this evolving landscape.
